Serum thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantation

Bone Marrow Transplantation

Volumn 19, Issue 8, 1997, Pages 771-775

  Shimazaki, C ^a,b   Inaba, T ^b   Uchiyama, H ^a   Sumikuma, T ^a   Kikuta, T ^a   Hirai, H ^a   Sudo, Y ^a   Yamagata, N ^a   Ashihara, E ^a   Goto, H ^a   Murakami, S ^a   Haruyama, H ^a   Fujita, N ^b   Nakagawa, M ^a  

^a Shakai Hoken Kyoto Hospital   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

PBSCT; Platelet; Thrombopoietin

Indexed keywords

CD34 ANTIGEN; THROMBOPOIETIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MEGAKARYOPOIESIS; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

EID: 17144456144     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700747     Document Type: Article

References (35)

1. Kessinger A, Armitage JO. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 1991; 77: 211-213.
2. Gale RP, Henon P, Juttner C. Blood stem cell transplants come of age. Bone Marrow Transplant 1992; 9: 151-155.
3. Demuynck H, Delforge M, Zachee P et al. An update on peripheral blood progenitor cell transplantation. Ann Hematol 1995; 71: 29-33.
4. Gordon MY, Greaves MF. Physiological mechanisms of stem cell regulation in bone marrow transplantation and hematopoiesis. Bone Marrow Transplant 1989; 4: 335-338.
5. Cairo MS, Suen Y, Sender L. Circulating granulocyte colony-stimulating factor (G-CSF) levels after allogeneic and autologous bone marrow transplantation: endogenous G-CSF production correlates with myeloid engraftment. Blood 1992; 79: 1869-1873.
6. Kawano Y, Takaue Y, Saito S et al. Granulocyte colony-stimulating factor (CSF), macrophage-CSF, granulocyte-macrophage CSF, interleukin-3, and interleukin-6 levels in sera from children undergoing blood stem cell autografts. Blood 1993; 81: 856-860.
7. Miksitis K, Beyer J, Siegert W. Serum concentration of G-CSF during high-dose chemotherapy with autologous stem cell rescue. Bone Marrow Transplant 1993; 11: 375-377.
8. Haas R, Gericke G, Witt B, Cayeux S, Hunstein W. Increased serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantation. Exp Hematol 1993; 21: 109-113.
9. Uchiyama H, Shimazaki C, Fujita N et al. Kinetics of serum cytokines in adults undergoing peripheral blood progenitor cell transplantation. Br J Haematol 1994; 88: 639-642.
10. Baiocchi G, Scambia G, Benedetti P et al. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery. Cancer Res 1993; 53: 1297-1303.
11. Testa U, Martucci R, Rutella S et al. Autologous stem cell transplantation: release of early and late acting growth factors relates with hematopoietic ablation and recovery. Blood 1994; 84: 3532-3539.
12. de Sauvage FJ, Haas PE, Spencer SD et al. Stimulation of megakaryopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533-565.
13. Kaushansky K, Lok S, Holly RD et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994; 369: 568-571.
14. Bartley TD, Bogenberger J, Hunt P et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994; 77: 1117-1124.
15. Kato T, Ogami K, Shimada Y et al. Purification and characterization of thrombopoietin. J Biochem 1995; 118: 229-236.
16. Tahara T, Usuki K, Sato H et al. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with hematopoietic disorders. Br J Haematol 1996; 93: 783-788.
17. Shimazaki C, Oku N, Ashihara E et al. Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 1992; 10: 341-346.
18. Teramura M, Katahira J, Hoshino S et al. Clonal growth of human megakaryocyte progenitor in serum free cultures; effect of recombinant human interleukin 3. Exp Hematol 1988; 16: 843-848.
19. Lotem J, Shabo Y, Sachs L. Regulation of megakaryocyte development by interleukin-6. Blood 1989; 74: 1545-1551.
20. Bruno E, Briddell RA, Cooper RJ, Hoffman R. Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells. Exp Hematol 1991; 19: 378-381.
21. Metcalf D, Hilton D, Nicola NA. Leukemia inhibitory factor can potentiate murine megakaryocyte production in vitro. Blood 1991; 77: 2150-2153.
22. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995; 85: 2720-2730.
23. Bernstein SH, Baer MR, Lawrence D et al. Serial determination of thrombopoietin (TPO), IL-3, IL-6, IL-11 and leukemia inhibitory factor (LIF) levels in patients undergoing chemotherapy for acute myeloid leukemia (AML). Blood 1995; 86 (Suppl. 1): 46 (Abstr. 170).
24. Nichol JL, Hokom MM, Hornkohl A et al. Megakaryocyte growth and development factor analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. J Clin Invest 1995; 95: 2973-2978.
25. Fielder PJ, Gurney AL, Stefanich E et al. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood 1996; 87: 2154-2161.
26. Stoffel R, Wiestner A, Skoda RC. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 1996; 87: 567-573.
27. Shimazaki C, Uchiyama T, Fujita N et al. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation. Exp Hematol 1995; 23: 1497-1502.
28. Layton JE, Hockman H, Sheridan WP, Morstyn G. Evidence for a novel in vivo control of granulopoiesis: mature cell-related control of a regulatory growth factor. Blood 1989; 74: 1303-1307.
29. Bartocci A, Mastrogiannis DS, Migliorati G et al. Macrophage specifically regulate the concentration of their own growth factor in the circulation. Proc Natl Acad Sci USA 1987; 84: 6179-6183.
30. Cebon JS, Bury RW, Lieschke GJ, Morstyn G. The effect of dose and route of administration on the pharmacokinetics of granulocyte-macrophage colony-stimulating factor. Eur J Cancer 1990; 26: 1064-1069.
31. Goldberg MA, Gaut CC, Bunn HF. Erythropoietin mRNA levels are governed by both the rate of gene transcription and post-transcriptional events. Blood 1991; 77: 271-276.
32. McCarty JM, Sprugel KH, Fox NE et al. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 1995; 86: 3668-3675.
33. Takamatsu Y, Akashi K, Harada M et al. Cytokine production by peripheral blood monocytes and T cells during haemopoietic recovery after intensive chemotherapy. Br J Haematol 1993; 83: 21-27.
34. Shimada Y, Kato T, Ogami K et al. Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell line. Exp Hematol 1995; 23: 1388-1396.
35. Molineux G, Hartley C, McElroy P et al. Megakaryocyte growth and development factor accelerates platelet recovery in peripheral blood progenitor cell transplant recipients. Blood 1996; 88: 366-376.